InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Goldberg Itzhak, Autre. Director active across 1 company, notably Angion Biomedica Corp.. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €217k. History available since 24 June 2021. The latest transaction was filed on 1 July 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Itzhak Goldberg is associated with Angion Biomedica Corp. Although his role is not specified, he contributes to the company's mission in the biopharmaceutical field. His expertise is valuable for developing innovative therapeutic solutions. He plays a role in the strategy and governance of the company.